Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes
โ Scribed by M. Flint Beal; Ross A. Clevens; Michael F. Mazurek
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 530 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0887-4476
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objectives Early and accurate diagnosis of Dementia with Lewy Bodies (DLB) to allow the appropriate clinical treatment is a priority, given reports of severe neuroleptic sensitivity and a preferential response to cholinesterase inhibitors in these patients. There have been suggestio
Objective. To compare the proยฎle of neuropsychiatric symptoms in patients with Parkinson's disease with dementia (PDD) and patients with Alzheimer's disease (AD). Design. Cross-sectional survey of a population-based sample of patients with PDD and AD patients matched for age, sex, and Mini-Mental S
## Abstract We compared the clinical and neuropsychological pattern of dementia with Lewy bodies (DLB) to Alzheimer's disease (AD) and Parkinson's disease with dementia (PDโd). Sixteen patients clinically diagnosed with DLB were compared with two groups of patients with PDโd (n = 15) and AD (n = 16